TITLE

Markers predicted response to Cox-2 inhibitors in colorectal cancer

AUTHOR(S)
Van Cutsem, Eric; Jacob, Harry S.
PUB. DATE
October 2008
SOURCE
Hem/Onc Today;10/25/2008, Vol. 9 Issue 19, p19
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses the data on Cox-2 inhibitors from the research "The Vioxx in Colorectal Cancer Therapy: Definition of Optimal Regime Trial," conducted by Rachel Midgley of the department of clinical pharmacology at Oxford University. The data shows that treatment with rofecoxib was not able to improve OS or protect against recurrence in patients with colorectal cancer.
ACCESSION #
34781538

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics